BrianMSlomovitzMD
Obstetrics & Gynecology • Fort Lauderdale, FLGynecologic Oncology
Division Chief Gynecologic Oncology
Dr. Slomovitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1600 S Andrews Ave
Fort Lauderdale, FL 33316Phone+1 954-355-4345Fax+1 954-527-4889- Is this information wrong?
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2002 - 2006
New York Presbyterian Hospital (Cornell Campus)Residency, Obstetrics and Gynecology, 1998 - 2002
Rutgers New Jersey Medical SchoolClass of 1998
Certifications & Licensure
FL State Medical License 2014 - 2026
TX State Medical License 2002 - 2015
NJ State Medical License 2008 - 2015
NY State Medical License 1999 - 2014- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
- Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Start of enrollment: 2009 Sep 14
- Join now to see all
Publications & Presentations
PubMed
- Top advances of the year: Uterine cancer.Matthew Powell, Britt K Erickson, Brian Slomovitz, Ramez N Eskander> ;Cancer. 2024 Apr 15
- Vulvar cancer management and wrangling recurrent disease: A report from the society of gynecologic oncology journal club.Gien, L., Parker, J., Yoshida, E., Slomovitz, B., Nagel, C.> ;Gynecologic Oncology Reports. 2023 Dec 1
- 1 citationsThe promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.Isabelle Ray-Coquard, Bradley J Monk, Domenica Lorusso, Haider Mahdi, Vivek Upadhyay, Regina Graul, Amreen Husain, Mansoor Raza Mirza, Brian Slomovitz> ;International Journal of Gynecological Cancer. 2023 Dec 4
- Join now to see all
Press Mentions
Study Investigates Combination Treatment for Endometrial CancerMarch 28th, 2023- Ribociclib plus Letrozole Yields Responses in Recurrent Ovarian CancerMarch 27th, 2023
- CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian CancerMarch 26th, 2023
- Join now to see all
Committees
- Member, Uterine Corpus Committee, Gynecologic Oncology Group 2010 - Present
Professional Memberships
- Fellow
Hospital Affiliations
UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
Broward Health Medical CenterFort Lauderdale, Florida
Mount Sinai Medical CenterMiami Beach, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
